article thumbnail

Extensive pharmacological review on Bauhinia racemosa Lam medicinal plant whose leaves are used to make Indian cigarettes (beedi’s)

Pharmatutor

Extensive pharmacological review on Bauhinia racemosa Lam medicinal plant whose leaves are used to make Indian cigarettes (beedi’s) admin Fri, 07/26/2024 - 10:52 Devansh Mehta* M.Pharmacy in Pharmacology, M.B.A. devanshm84@gmail.com

article thumbnail

A Comprehensive Review on plant Sida cordifolia L. including its phyto-chemical status and pharmacological properties

Pharmatutor

including its phyto-chemical status and pharmacological properties admin Tue, 07/16/2024 - 15:09 ABOUT AUTHOR Devansh Mehta 1* Author : M.Pharmacy in Pharmacology, M.B.A. A Comprehensive Review on plant Sida cordifolia L. in Pharmaceutical Marketing and Hospital Administration, B.Pharmacy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Issues Guidance on Clinical Pharmacology for Peptide Drugs

PharmaTech

The guidance document discusses the impact of clinical pharmacology considerations on peptide drug development.

article thumbnail

As Viatris seeks growth in eye care, its Ocuphire-partnered dilation drop Ryzumvi wins FDA nod

Fierce Pharma

The FDA on Wednesday approved Viatris and Ocuphire’s Ryzumvi, also known as phentolamine ophthalmic solution, to treat pharmacologically-induced mydriasis, or dilation of the pupils. Viatris just notched a win on its quest to reach $1 billion in eye care sales by 2028. | The partners plan to make Ryzumvi available in the U.S.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

In this exclusive webinar, Dr. Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.

article thumbnail

Expert: The Evolving Landscape of Pharmacologic Research and Clinical Management of Symptoms in Borderline Personality Disorder

Pharmacy Times

Expert perspective on current research, treatment approaches, and clinical considerations for pharmacologic management of borderline personality disorder

article thumbnail

To Give Rare Disease Patients Hope, the FDA Must Re-Focus its Efforts

MedCity News

This would bring together specialized staff and resources from multiple review divisions to leverage their expertise about different bodily systems, trial designs, pharmacology, and other specialized fields. To bring cross-agency clinical leaders together, the FDA should establish a Center of Excellence for Rare Diseases.

FDA 73